Efficacy of Evolocumab in patients with arteriosclerosis obliterans.
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Evolocumab (Primary)
- Indications Arteriosclerosis obliterans; Dyslipidaemias
- Focus Therapeutic Use
Most Recent Events
- 04 Jun 2018 New trial record